SlobodanGul

10/13/2021 Anti-censorship backup from https://www.youtube.com/watch?v=hN8QEtPQ4BQ Presentation by Dr. Jessica Rose at https://i-do-not-consent.netlify.app/ Presentation of VAERS data to the World Council for Health on October 11, 2021. https://worldcouncilforhealth.org/ Please make a donation to support Dr. Rose's research. You can find the link on my website: https://i-do-not-consent.netlify.app

Presented at the 78th Annual Meeting of the Association of American Physicians and Surgeons, October 2, 2021. Help Dr Peter McCullough with legal, IT, and travel costs. Donate here: https://givesendgo.com/G2DR5

09/06/2021 Anti-censorship backup from https://www.youtube.com/watch?v=Y4MViwU3XOo Presentation by Dr. Jessica Rose at https://i-do-not-consent.netlify.app/ Hello all! Welcome to the long-awaited VAERS update! This update is for VAERS data from the August 27th update and covers all sorts of goodies! Like total counts, missing data, lost safety signals, escape mutants and more! The presentation was officially made for the Canadian COVID Care Alliance and is sectioned according to Safety and Efficacy. I really hope you like it! If you do like it and want to support me, please make a small donation to the Joshua Kuntz Fellowship. All donations go directly to me to fund this research. We honor Joshua's life and his passing with this Fellowship in our fight to bring science and truth to light in dark times. Please go to: https://ipaknowledge.org/joshua-kuntz-research-fellowship.php Thank you!

Update concerning Dr. Didier Raoult's latest paper -- July 2021 This is a quick update on Dr. Raoult's latest paper on early treatment of covid 19, which includes a case series with 1459 high-risk patients, and the corresponding efficscy thresholds. Raoult's paper: M. Million, J-C. Lagier, H. Tissot-DuPont, I. Ravaux, C. Dhiver, C. Tomei, N Cassir, L. DeLorme, S. Cortaredona, S. Gentile, E. Jouve, A. Giraud-Gatineau, H. Chaudet, L. Camoin-Jau, P. Colson, P. Gautret, P-E. Fournier, B. Maille, J-C. Deharo, P. Habert, J-Y. Gaubert, A. Jacquier, S. Honore, K. Guillon-Lorvellec, Y. Obadia, P. Parola, P. Brouqui, D. Raoult. "Early Treatment with Hydroxychloroquine and Azithromycin in 10,429 COVID-19 Outpatients: A Monocentric Retrospective Cohort Study", Reviews in Cardiovascular Medicine 22 (2021), 1063-1072 https://rcm.imrpress.com/EN/10.31083/j.rcm2203116 Other related presentations: H.A. Risch: Hydroxychloroquine and its friends https://rumble.com/vj4pop-hydroxychloroquine-and-its-friends.html P.A. McCullough: Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment for COVID-19 and Update on Vaccine Safety https://rumble.com/vji3dj-peter-a.-mccullough-seminar-at-ihu.html D. Raoult: Management of COVID-19 in Marseille Institute. https://rumble.com/vjjjaf-management-of-covid-19-in-marseille-institute.html E. Gkioulekas: On the Zelenko protocol: The road not taken https://faculty.utrgv.edu/eleftherios.gkioulekas/presentations/2021-zelenko-protocol.html Help Dr Peter McCullough with legal, IT, and travel costs. Donate here: https://givesendgo.com/G2DR5

Management of COVID-19 in Marseille Institute. https://www.youtube.com/watch?v=inZJQy2IpAY

Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment for COVID-19 and Update on Vaccine Safety References: P.A. McCullough, R.J.Kelly, G. Ruocco, E. Lerma, J. Tumlin, K.R.Wheelan, N. Katz, N.E. Lepor, K. Vijay, H. Carter, B. Singh, S.P. McCullough, B.K. Bhambi, A. Palazzuoli, G.M. De Ferrari, G.P.Milligan, T. Safder, K.M. Tecson, H.A. Risch: "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection", The American Journal of Medicine 134 (2020), 16-22 https://doi.org/10.1016/j.amjmed.2020.07.003 P.A. McCullough. "Innovative Early Sequenced Multidrug Therapy for Sars-Cov-2 (Covid-19) Infection to Reduce Hospitalization and Death", International Journal of Medical Science and Clinical Invention 7 (2020), 5139-5150 https://doi.org/10.18535/ijmsci/v7i12.02 P.A. McCullough, P.E. Alexander, R. Armstrong, C. Arvinte, A.F. Bain, R.P. Bartlett, R.L. Berkowitz, A.C. Berry, T.J. Borody, J.H. Brewer, A.M. Brufsky, T. Clarke, R. Derwand, A. Eck, J. Eck, R.A. Eisner, G.C. Fareed, A. Farella, S.N.S. Fonseca, C.E. Geyer, Jr., R.S. Gonnering, K.E. Graves, K.B.V. Gross, S. Hazan, K.S. Held, H. Thomas Hight, S. Immanuel, M.M. Jacobs, J.A. Ladapo, L.H. Lee, J. Littell, I. Lozano, H.S. Mangat, B. Marble, J.E. McKinnon, L.D. Merritt, J.M. Orient, R. Oskoui, D.C. Pompan, B.C. Procter, C. Prodromos, J.C. Rajter, J-J. Rajter, C. V.S. Ram, S.S. Rios, H.A. Risch, M.J.A. Robb, M. Rutherford, M. Scholz, M.M. Singleton, J.A. Tumlin, B.M. Tyson, R.G. Urso, K. Victory, E.L. Vliet, C.M. Wax, A.G. Wolkoff, V. Wooll, V. Zelenko. "Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)", Reviews in Cardiovascular Medicine 21 (4) (2020), 517-530 https://rcm.imrpress.com/EN/Y2020/V21/I4/517 Mirrored from: https://www.youtube.com/watch?v=e6CA3q0qZdU Help Dr Peter McCullough with legal, IT, and travel costs. Donate here: https://givesendgo.com/G2DR5

Dr. Harvey Risch's seminar presentation on hydroxychloroquine to the IHU Mediterraine-Infection research hospital. References: H.A. Risch. "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis", American Journal of Epidemiology 189 (2020), 1218-1226 https://doi.org/10.1093/aje/kwaa093 H.A. Risch. "Hydroxychloroquine in Early Treatment of High-Risk COVID-19 Outpatients: Efficacy and Safety Evidence." Sixth version, updated June 17, 2021. https://earlycovidcare.org/wp-content/uploads/2021/09/Evidence-Brief-Risch-v6.pdf Original video available at: https://www.youtube.com/watch?v=x2DxP-6wHoY

Want to know why the early treatment protocol for SARS-CoV-2 by Dr. Vladimir Zev Zelenko should have been adopted no later than April 29 2020 by every nation around the world? And why the decision should have been an easy one to make? Start here. Then get all the details in my extended 2-hour research presentation. Dr. Zelenko's March letter https://tinyurl.com/yx2cxf6q https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Vladimir-Zelenko-treatment.pdf Dr. Zelenko's April letter https://tinyurl.com/yxk8ssco https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Zelenko-memo-April.pdf Case fatality rate data https://ourworldindata.org/mortality-risk-covid#the-case-fatality-rate My extended 2-hour research presentation https://rumble.com/vfhht5-on-the-zelenko-protocol-the-road-not-taken.html Some of the links above were censored by Google Drive. Help Dr Peter McCullough with legal, IT, and travel costs. Donate here: https://givesendgo.com/G2DR5

Dr. Vladimir Zev Zelenko proposed an early outpatient treatment for the SARS-CoV-2 pandemic in two letters dated March 24, 2020 and April 28, 2020, that were then followed up with a research publication dated December 2020. We introduce a mathematical technique for conducting rapid statistical analysis of observational data that can be used to make emergency decisions in the midst of a crisis, on whether to deploy new proposed treatments based on repurposed drugs. The technique is limited to the special case of repurposed drugs that have an known excellent safety record, and it can be used to rapidly establish whether the proposed treatment works, while leaving open the question of how well it works. Note: At this time, this is a non-peer reviewed preliminary research report. For the slides and an HD video download, go to: https://faculty.utrgv.edu/eleftherios.gkioulekas/presentations/2021-zelenko-protocol.html Dr. Zelenko's March letter https://tinyurl.com/yx2cxf6q https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Vladimir-Zelenko-treatment.pdf Dr. Zelenko's April letter https://tinyurl.com/yxk8ssco https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Zelenko-memo-April.pdf Dr. Zelenko's June letter https://tinyurl.com/y4hw7dye https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Zelenko-memo-June-Dr-Shemtov-letter.pdf Some of the links above were censored by Google Drive. Help Dr Peter McCullough with legal, IT, and travel costs. Donate here: https://givesendgo.com/G2DR5

In the two-layer quasi-geostrophic model, the friction between the flow at the lower layer and the surface boundary layer, placed beneath the lower layer, is modeled by the Ekman term, which is a linear dissipation term with respect to the horizontal velocity at the lower layer. The Ekman term appears in the governing equations asymmetrically; it is placed at the lower layer, but does not appear at the upper layer. A variation, proposed by Phillips and Salmon, uses extrapolation to place the Ekman term between the lower layer and the surface boundary layer, or at the surface boundary layer. We present theoretical results that show that in either the standard or the extrapolated configurations, the Ekman term dissipates energy at large scales, but does not dissipate potential enstrophy. It also creates an approximately symmetric stable distribution of potential enstrophy between the two layers. The behavior of the Ekman term changes fundamentally at small scales. Under the standard formulation, the Ekman term will unconditionally dissipate energy and also dissipate, under very minor conditions, potential enstrophy at small scales. However, under the extrapolated formulation, there exist small "negative regions", which are defined over a two-dimensional phase space, capturing the distribution of energy per wavenumber between baroclinic energy and barotropic energy, and the distribution of potential enstrophy per wavenumber between the upper layer and the lower layer, where the Ekman term may inject energy or potential enstrophy. For the slides, go to: https://faculty.utrgv.edu/eleftherios.gkioulekas/presentations/2020-asymmetric-ekman-term.html The corresponding research publication is: E. Gkioulekas: "The role of the asymmetric Ekman dissipation term on the energetics of the two-layer quasi-geostrophic model", Physica D 403 (2020), 132372, 17 pp. https://faculty.utrgv.edu/eleftherios.gkioulekas/papers/submitted/ekman-term-study.pdf https://doi.org/10.1016/j.physd.2020.132372

The standard technique for solving equations with radicals is to square both sides of the equation as many times as necessary to eliminate all radicals. Because the procedure violates logical equivalence, it results in extraneous solutions that do not satisfy the original equation, making it necessary to check all solutions against the original equation. We propose alternative solution procedures that are rigorous and simple to execute where the extraneous solutions can be identified without verification against the original equation. For the slides, go to: https://faculty.utrgv.edu/eleftherios.gkioulekas/presentations/2021-radical-equations.html The corresponding research publications are: E. Gkioulekas: "Using restrictions to accept or reject solutions of radical equations", International Journal of Mathematical Education in Science and Technology 49 (2018), 1278-1292 https://faculty.utrgv.edu/eleftherios.gkioulekas/papers/025-radical-equations-depth-one.pdf https://doi.org/10.1080/0020739X.2018.1458341 E. Gkioulekas: "Solving parametric radical equations with depth 2 rigorously using the restriction set method", International Journal of Mathematical Education in Science and Technology 51 (2020), 1255-1277 https://faculty.utrgv.edu/eleftherios.gkioulekas/papers/submitted/parametric-rad-equations-depth-two.pdf https://doi.org/10.1080/0020739X.2020.1807066